A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

NCT06644118 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: OL-101 infusion

Sponsor

Zhejiang University

Collaborators

[object Object]